Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUMP.L Regulatory News (BUMP)

  • There is currently no data for BUMP

Director/PDMR Shareholding

1 Mar 2022 07:00

RNS Number : 1099D
Seraphine Group PLC
01 March 2022
 

1 March 2022

Seraphine Group plc

("Seraphine" or the "Company")

Notification and public disclosure of transaction by PDMR

Seraphine Group plc (LON: BUMP), the international digitally led maternity and nursing wear brand, announces that on 28 February 2022 an award over 307,750 ordinary shares of 1 pence each in the Company was granted to the Company's new Chief Financial Officer, Lee Williams.

The award comprises two distinct equal parts (part one and part two) each relating to 153,875 shares and each structured as a nil cost option. The parts shall ordinarily vest on 28 February 2023 in respect of part one and on 28 February 2024 in respect of part two, in each case subject to continued service.

The award was granted under a one-off share award arrangement reflecting terms agreed in connection with Mr Williams' recruitment relating to the buy-out of forfeited bonus from previous employment. To the extent the award vests it will be satisfied with existing shares sourced in the market. No newly issued shares shall be used in connection with the award.

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Lee Williams

 

2

Reason for Notification

a)

Position/status

Chief Financial Officer

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Seraphine Group plc

b)

LEI

254900CQ8TMKUDD0L296

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each in Seraphine Group plc

GB00BNXGTY25

 

b)

Nature of the transaction

Grant of nil cost option over ordinary shares under a one-off share award arrangement.

The option shall vest in equal parts on the first and second anniversary of grant respectively subject to continued service.

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

Nil

 

307,750

 

d)

Aggregated information

- Aggregated volume

- Price

 

Not applicable - single transactions

e)

Date of the transaction

28 February 2022

f)

Place of the transaction

Outside a trading venue

 

ENDS

For further information, please contact:

 

Seraphine Group plc

David N Williams, Chief Executive Officer

 

via FTI Consulting

FTI Consulting (PR adviser to Seraphine)

Alex Beagley

Rafaella de Freitas

 

+44 (0)20 3727 1000

Seraphine@fticonsulting.com

 

About Seraphine

Seraphine is an international digitally-led maternity and nursing wear brand with a diverse range of innovative maternity and nursing products serving an under-competed global market.

 

Seraphine was founded in 2002 with the vision of creating desirable clothes which women would want to wear even if they were not pregnant, and this ethos remains true to this day. The Group has over 18 years' experience designing and developing maternity and nursing wear for women from first trimester to post-partum and nursing products.

 

The Group has achieved global brand recognition through its rapidly growing digital platform, which in the year to 4 April 2021, contributed to approximately 89% of revenue. The Group currently exports products to customers in over 120 countries globally, with the Group's largest markets being Europe, North America and the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHVVLFLLLLEBBQ
12
Date   Source Headline
31st Mar 20237:00 amRNSUpdate on Acceptance Levels
27th Mar 202312:58 pmRNSNotification of Major Holdings
27th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20235:58 pmRNSPDMR Shareholding and Total Voting Rights
23rd Mar 20237:00 amRNSOffer Update - Notice of Offer Closing
9th Mar 20239:27 amRNSForm 8.3 - Seraphine Group PLC
8th Mar 20235:45 pmRNSSeraphine Group
8th Mar 202311:37 amRNSCancellation of Listing
8th Mar 20238:20 amRNSForm 8.3 - Seraphine Group PLC
8th Mar 20237:00 amRNSOffer Declared Unconditional
7th Mar 20237:00 amRNSUpdate on Acceptance Levels
1st Mar 20239:12 amRNSForm 8.3 - SERAPHINE GROUP PLC
28th Feb 20237:00 amRNSUpdate on Acceptance Levels
23rd Feb 20238:37 amRNSForm 8.3 - SERAPHINE GROUP PLC
21st Feb 20237:00 amRNSUpdate on Acceptance Levels
7th Feb 20238:27 amRNSForm 8.3 - Seraphine Group PLC
3rd Feb 202311:45 amRNSForm 8.3 - Seraphine Group plc
1st Feb 20233:29 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 20233:28 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 20233:24 pmRNSForm 8.3 - Seraphine Group Plc
1st Feb 202312:11 pmRNSForm 8 (OPD) - Seraphine Group PLC
1st Feb 20239:17 amRNSForm 8.3 – John Bailey
31st Jan 20233:06 pmRNSForm 8 (OPD) - Seraphine Group plc
30th Jan 20235:46 pmRNSPosting of Offer Document
30th Jan 20238:54 amRNSForm 8.3 - SERAPHINE GROUP PLC
27th Jan 20239:12 amRNSForm 8.3 - SERAPHINE GROUP PLC
26th Jan 20238:28 amRNSForm 8.3 - Seraphine Group PLC
25th Jan 20232:08 pmRNSForm 8.3 - Seraphine Group PLC
25th Jan 20238:43 amRNSForm 8.3 - SERAPHINE GROUP PLC
24th Jan 20238:36 amRNSForm 8.3 - Seraphine Group PLC
23rd Jan 20231:49 pmRNSForm 8.3 - Seraphine Group PLC
23rd Jan 202312:41 pmGNWForm 8.3 - [Seraphine Group plc - Opening Declaration - 20 01 2023] - (CGAML)
23rd Jan 20238:42 amRNSForm 8.3 - SERAPHINE GROUP PLC
20th Jan 20232:28 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Seraphine Group plc
20th Jan 202312:01 pmRNSForm 8.3 - Seraphine Group PLC
20th Jan 202310:56 amRNSForm 8.3 - SERAPHINE GROUP PLC
20th Jan 20237:00 amRNSRecommended Cash Offer
22nd Dec 20227:00 amRNSChange of Adviser
14th Dec 20224:38 pmRNSNotification of Major Holdings
8th Dec 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSCapital Reduction
8th Nov 20227:00 amRNSHalf Year Trading Update
30th Sep 20223:49 pmRNSDirector/PDMR Shareholding Grant of LTIP Awards
27th Sep 20222:36 pmRNSNotification of Major Holdings
21st Sep 20222:08 pmRNSResult of AGM
19th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 202212:49 pmRNSNotice of AGM and Annual Report and Accounts
3rd Aug 202211:29 amRNSDirector/PDMR Shareholding
3rd Aug 20227:00 amRNSDirector/PDMR Shareholding
1st Aug 20227:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.